🇺🇸 FDA

Intelligence · Clinical Pipeline

United Therapeutics Europe Pipeline

All ClinicalTrials.gov programs at United Therapeutics Europe — phase, modality, and trial IDs.

Programs
1,032

Quick answer

United Therapeutics Europe has 1,032 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Doxycycline

    United Therapeutics Europe Ltd

    Advanced Malignant Neoplasm

    phase 2 small molecule completed

    1 trial

  2. Drug COVID19-0001-USR

    United Therapeutics Europe Ltd

    SARS-CoV-2 Infection

    phase 2 small molecule active

    1 trial

  3. Durvalumab

    United Therapeutics Europe Ltd

    Stage IB Hepatocellular Carcinoma AJCC v8

    phase 2 mab active

    1 trial

  4. E. coli ETVAX

    United Therapeutics Europe Ltd

    Diarrhea

    phase 2 mab completed

    1 trial

  5. Elliptical exercise

    United Therapeutics Europe Ltd

    Adult

    phase 2 other completed

    1 trial

  6. Enfortumab vedotin

    United Therapeutics Europe Ltd

    Metastatic Urothelial Carcinoma

    phase 2 small molecule active

    1 trial

  7. Enzalutamide 40mg

    United Therapeutics Europe Ltd

    Metastatic Castration-Resistant Prostate Cancer (mCRPC)

    phase 2 small molecule active

    1 trial

  8. Epcoritamab

    United Therapeutics Europe Ltd

    Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

    phase 2 mab active

    1 trial

  9. Erlotinib

    United Therapeutics Europe Ltd

    Non-Small Cell Lung Cancer

    phase 2 small molecule completed

    1 trial

  10. Erlotinib

    United Therapeutics Europe Ltd

    Lung Cancer

    phase 2 small molecule completed

    1 trial

  11. Etanercept

    United Therapeutics Europe Ltd

    Lupus Erythematosus, Discoid

    phase 2 small molecule completed

    1 trial

  12. Exercise Programme

    United Therapeutics Europe Ltd

    Parkinson's Disease

    phase 2 other completed

    1 trial

  13. Exercise Training

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 other completed

    1 trial

  14. FGF-2

    United Therapeutics Europe Ltd

    Tympanic Membrane Perforation

    phase 2 small molecule completed

    1 trial

  15. FMP2.1/AS01B

    United Therapeutics Europe Ltd

    Plasmodium Falciparum Malaria

    phase 2 mab completed

    1 trial

  16. Famotidine

    United Therapeutics Europe Ltd

    2019 Novel Coronavirus Disease

    phase 2 small molecule terminated

    3 trials

  17. Fentanyl

    United Therapeutics Europe Ltd

    Healthy

    phase 2 small molecule completed

    1 trial

  18. Fisetin

    United Therapeutics Europe Ltd

    Femoroacetabular Impingement

    phase 2 small molecule active

    1 trial

  19. Fluorouracil

    United Therapeutics Europe Ltd

    Clinical Stage II Esophageal Adenocarcinoma AJCC v8

    phase 2 small molecule active

    1 trial

  20. Fluorouracil

    United Therapeutics Europe Ltd

    Metastatic Biliary Tract Carcinoma

    phase 2 small molecule active

    1 trial

  21. Fresh Frozen Plasma (FFP)

    United Therapeutics Europe Ltd

    Anticoagulant Reversal

    phase 2 mab terminated

    1 trial

  22. Fulvestrant

    United Therapeutics Europe Ltd

    Advanced Breast Cancer

    phase 2 small molecule active

    1 trial

  23. Fulvestrant with Enzalutamide

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 small molecule completed

    1 trial

  24. Functional Precision Oncology

    United Therapeutics Europe Ltd

    Breast Cancer Recurrent

    phase 2 other active

    1 trial

  25. G03-52-01

    United Therapeutics Europe Ltd

    Healthy

    phase 2 small molecule completed

    1 trial

  26. GGTA1 KO Thymokidney

    United Therapeutics Europe Ltd

    ESRD (End-Stage Renal Disease)

    phase 2 mab active

    1 trial

  27. GIP/GLP-1a

    United Therapeutics Europe Ltd

    Non-Alcoholic Fatty Liver Disease

    phase 2 small molecule active

    1 trial

  28. GSK influenza virus H5N1 vaccine 1557484A

    United Therapeutics Europe Ltd

    Influenza

    phase 2 mab terminated

    1 trial

  29. Galinpepimut-S + Montanide + GM-CSF

    United Therapeutics Europe Ltd

    Malignant Pleural Mesothelioma

    phase 2 mab completed

    1 trial

  30. Gallium Ga 68 Gozetotide

    United Therapeutics Europe Ltd

    Hepatocellular Carcinoma

    phase 2 small molecule completed

    1 trial

  31. Gluten- and casein-free diet

    United Therapeutics Europe Ltd

    Autism

    phase 2 other completed

    1 trial

  32. Glyoxalase 1 (Glo1) inducer

    United Therapeutics Europe Ltd

    Glucose Intolerance

    phase 2 other completed

    1 trial

  33. Granexin® gel (200 μM)

    United Therapeutics Europe Ltd

    Second Degree Burn

    phase 2 small molecule terminated

    1 trial

  34. Green tea

    United Therapeutics Europe Ltd

    Lung Cancer Prevention

    phase 2 other completed

    1 trial

  35. Group A FMP2.1/AS01B

    United Therapeutics Europe Ltd

    Malaria

    phase 2 mab completed

    1 trial

  36. HB-adMSC

    United Therapeutics Europe Ltd

    COVID-19

    phase 2 mab terminated

    1 trial

  37. HTNV/PUUV DNA vaccine

    United Therapeutics Europe Ltd

    Hemorrhagic Fever With Renal Syndrome

    phase 2 mab completed

    1 trial

  38. Human Mesenchymal Stromal Cells

    United Therapeutics Europe Ltd

    Respiratory Distress Syndrome, Adult

    phase 2 mab completed

    1 trial

  39. Hydrogen Peroxide

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 small molecule active

    1 trial

  40. Hyperpolarized 129Xenon gas

    United Therapeutics Europe Ltd

    Pulmonary Vascular Disease

    phase 2 small molecule completed

    1 trial

  41. IL-1Ra Kineret®

    United Therapeutics Europe Ltd

    Intracerebral Haemorrhage

    phase 2 small molecule completed

    1 trial

  42. IV Remodulin

    United Therapeutics Europe Ltd

    Persistent Pulmonary Hypertension of the Newborn

    phase 2 small molecule terminated

    1 trial

  43. Ibrutinib

    United Therapeutics Europe Ltd

    Asymptomatic COVID-19 Infection Laboratory-Confirmed

    phase 2 small molecule terminated

    1 trial

  44. Ibrutinib 560 mg

    United Therapeutics Europe Ltd

    Mantle Cell Lymphoma

    phase 2 small molecule active

    1 trial

  45. Ibuprofen

    United Therapeutics Europe Ltd

    Tonsillectomy

    phase 2 small molecule completed

    1 trial

  46. Imatinib Mesylate

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 2 small molecule active

    1 trial

  47. Impedance Threshold Device

    United Therapeutics Europe Ltd

    Hypotension

    phase 2 other completed

    1 trial

  48. Inhaled Treprostinil

    United Therapeutics Europe Ltd

    Sarcoidosis

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does United Therapeutics Europe have?

1,032 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.